English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 95906/126496 (76%)
Visitors : 31745978      Online Users : 313
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    政大機構典藏 > 教育學院 > 教育學系 > 期刊論文 >  Item 140.119/75540
    Please use this identifier to cite or link to this item: http://nccur.lib.nccu.edu.tw/handle/140.119/75540

    Title: Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations
    Authors: Huang, H.-N.;Huang, W.-C.;Lin, C.-H.;Huang, Hsin Ying
    Contributors: 教育系
    Keywords: phosphatidylinositol 3 kinase;phosphatidylinositol 3;4;5 trisphosphate 3 phosphatase;phosphoinositide 3 kinase catalytic subunit alpha;protein kinase B;unclassified drug;uvomorulin;zinc finger protein;zinc finger protein 217;adult;Article;cancer prognosis;cancer size;cancer survival;chromosome;chromosome mutation;clear cell carcinoma;down regulation;enzyme activation;female;fluorescence in situ hybridization;gene amplification;gene expression;gene identification;gene locus;gene sequence;genetic association;human;human tissue;immunohistochemistry;major clinical study;ovary carcinoma;overall survival;polymerase chain reaction;signal transduction;somatic mutation
    Date: 2014-11
    Issue Date: 2015-06-03 11:13:38 (UTC+8)
    Abstract: This study aims to evaluate the relationships between chromosome 20q13.2 zinc finger protein 217 (ZNF217) locus amplification, ZNF217 expression, E-cadherin expression, and PI3K-Akt pathway alterations (activating PIK3CA mutations or loss of phosphatase and tensin homolog [PTEN] expression), and whether these molecular alterations can predict the clinical survival data in ovarian clear cell carcinoma (OCCC) patients. Samples and clinical data of 72 OCCC patients were collected. Chromosome 20q13.2 ZNF217 locus amplification was detected by fluorescence in situ hybridization. ZNF217, E-cadherin and PTEN expression were assessed using immunohistochemical stain. PIK3CA mutation was identified by PCR-amplified gene sequencing. Cox proportional hazard regression model was used to estimate the adjusted hazard ratios of survival. Chromosome 20q13.2 ZNF217 locus amplification was detected in 31% (22/72) of cases, and ZNF217 expression was increased in 40% (27/68) of cases. E-cadherin and PTEN expressions were decreased or lost in 44% (32/72) and 14% (10/72) of cases, respectively. Activating PIK3CA mutations were present in 35% (25/72) of cases. Thirty-three OCCC patients (46%) showed activating PI3K-Akt pathway alterations. Chromosome 20q13.2 ZNF217 locus amplification was significantly associated with decreased E-cadherin expression (P =.001). In contrast, ZNF217 expression was not related to ZNF217 amplification or E-cadherin expression. In OCCC patients with activating PI3k-Akt pathway, decreased E-cadherin expression (P =.033) and advanced Federation of Gynecology and Obstetrics stage (P =.014) predicted shorter overall survival. Two conclusions were raised in our study. First, ZNF217 plays a role in down-regulating E-cadherin expression and is a potential therapeutic target for OCCC patients. Second, E-cadherin expression is a prognostic marker for OCCC patients with activating PI3K-Akt pathway.
    Relation: Human Pathology, 45(11), 2318-2325
    Data Type: article
    DOI 連結: http://dx.doi.org/10.1016/j.humpath.2014.07.020
    DOI: 10.1016/j.humpath.2014.07.020
    Appears in Collections:[教育學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    2318-2325.pdf501KbAdobe PDF790View/Open

    All items in 政大典藏 are protected by copyright, with all rights reserved.

    社群 sharing

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback